Rheumatoid arthritis: assessing disease activity and outcome

ISSN： 1470-2118

Source： Clinical Medicine, Vol.10, Iss.3, 2010-06, pp. : 248-251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tocilizumab reduces disease activity in patients with systemic-onset juvenile idiopathic rheumatoid arthritis

Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Cardiovascular disease – the silent killer in rheumatoid arthritis

By Kumar Namita Armstrong David J

Clinical Medicine, Vol. 8, Iss. 4, 2008-08 ,pp. : 384-387

Royal College Of Physicians

Access to resources Recommend Favorite

Rheumatoid Arthritis: Genetic Variants as Biomarkers of Cardiovascular Disease

Current Pharmaceutical Design, Vol. 21, Iss. 2, 2015-01 ,pp. : 182-201

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches to Identifying Genetic Predictors of Clinical Outcome in Rheumatoid Arthritis

By Barton A. John S.

American Journal of PharmacoGenomics, Vol. 3, Iss. 3, 2003-01 ,pp. : 181-191

Adis International

Access to resources Recommend Favorite

Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis

By Kooloos Wouter M Wessels Judith AM van der Straaten Tahar Allaart Cornelia F Huizinga Tom WJ Guchelaar Henk-Jan

Pharmacogenomics, Vol. 11, Iss. 2, 2010-02 ,pp. : 163-175

Future Medicine

Access to resources Recommend Favorite